Wellington Management Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Wellington Management Group's ABUS Position: Q3 2026 in Review
Wellington Management Group increased its Arbutus Biopharma (ABUS) stake by 22% in Q3 2026, buying an estimated $500K and bringing the position to 565,442 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1550.
Wellington Management Group first reported a position in ABUS in Q4 2021 and has held it in 17 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Wellington Management Group held 565,442 shares of Arbutus Biopharma worth $2.7M as of Q3 2026.
- Wellington Management Group bought 103,796 Arbutus Biopharma shares in Q3 2026, an estimated $500K.
- Arbutus Biopharma made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1550 holding.
- Wellington Management Group first reported a position in Arbutus Biopharma in Q4 2021 and has held it in 17 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.